To further confirm our observations, we used 5xFAD mice, a transgenic AD mouse model, and found the expression of gal3 significantly upregulated in a time-dependent fashion from 6 to 18 months (Fig. 1d; suppl. This evidence concerns the gene LGALS3 and Alzheimer disease.